Radiation Leukemia

Radiation Leukemia is a type of cancer that affects the blood cells. It happens when someone is exposed to high levels of radiation, like from X-rays or nuclear power plants. This exposure can damage the DNA in the blood cells, causing them to grow uncontrollably and replace healthy blood cells. This can lead to problems like infections, bleeding, and anemia.

Condition

What people with Radiation Leukemia report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Radiation Leukemia?

NameHow it went

About Radiation Leukemia

What It Is

Radiation leukemia is a leukemia that develops after a person has been exposed to ionizing radiation, the high-energy kind used in radiation therapy and released by nuclear weapons or reactor accidents. Leukemia is a cancer of the blood-forming cells in the bone marrow. The marrow starts making large numbers of abnormal cells that crowd out the healthy ones, which can lead to anemia, infections and easy bleeding. Most radiation-related leukemias are acute myeloid leukemia (AML), a fast-growing leukemia, or a closely related bone marrow disorder called myelodysplastic syndrome (MDS). When the leukemia follows radiation therapy or chemotherapy given for an earlier illness, doctors call it therapy-related AML or a therapy-related myeloid neoplasm. This history matters because these leukemias tend to carry riskier genetic changes and are harder to treat than leukemia that appears without prior treatment.

Causes & Risk Factors

Ionizing radiation can damage the DNA in bone marrow cells, and sometimes that damage sets a cell on the path to leukemia. Most often the exposure was radiation therapy for an earlier cancer, frequently given together with chemotherapy. Because many people receive both, it is often impossible to say which treatment was responsible. The risk depends on how much radiation was given and which part of the body was treated. Leukemia linked to radiation or to a group of chemotherapy drugs called alkylating agents typically appears about 5 to 6 years after treatment, though it can arise anywhere from under a year to about 16 years later. High-dose exposure outside medicine also raises risk. Survivors of the atomic bombings in Japan had a sharply increased rate of leukemia, and their extra risk of AML persisted for decades. Chronic lymphocytic leukemia, a common slow-growing leukemia in older adults, has not been linked to radiation. The risk from imaging tests such as x-rays and CT scans is not well defined. If it exists, it is likely to be small, which is why clinicians try to limit unnecessary scans, especially for children and during pregnancy. For both imaging and radiation therapy, the medical benefit is almost always greater than the cancer risk. Most people who have had radiation never develop leukemia, and inherited factors may help explain why some do.

How It's Diagnosed

Leukemia is often first suspected from a complete blood count (CBC), a routine blood test that measures red cells, white cells and platelets. Low counts, or abnormal immature cells on a blood smear, lead to a bone marrow aspiration and biopsy, in which a small sample of liquid marrow and bone is taken to confirm the diagnosis and identify the type. Genetic testing of the leukemia cells is central. Leukemia after radiation commonly shows complex chromosome changes, especially involving chromosomes 5 and 7, or mutations in TP53, a gene that normally helps stop damaged cells from growing. These findings, rather than the original exposure itself, guide prognosis and treatment choices. Because some people who develop leukemia after cancer treatment carry an inherited cancer-risk gene, genetic counseling or inherited gene testing is worth considering when there is a strong family history of cancer.

Treatment Options

Treatment follows the approach used for AML, adjusted for the leukemia's genetic features, the person's age and fitness, and the lasting effects of earlier cancer treatment. The first goal is remission, meaning no detectable leukemia in the blood or marrow. For people healthy enough for intensive treatment, the main option is induction chemotherapy given in the hospital. A combined, liposome-packaged form of two standard chemotherapy drugs, daunorubicin and cytarabine (Vyxeos), is approved specifically for newly diagnosed therapy-related AML; in a study of adults aged 60 to 75, it produced more remissions and longer survival than the standard combination. For people who are older or cannot tolerate intensive chemotherapy, lower-intensity treatment such as venetoclax (Venclexta), a targeted pill, combined with a gentler chemotherapy is an option. An allogeneic stem cell transplant, which replaces the person's marrow with blood-forming cells from a donor, offers the best chance of long-term control for selected people. It carries serious risks, including infection and graft-versus-host disease, in which donor immune cells attack the body, and the leukemia can still return. Clinical trials are a reasonable option to discuss at any stage.

What to Expect

Radiation-related leukemia is a serious diagnosis, and outcomes are generally worse than for leukemia that appears without prior treatment. Results vary widely with the genetic findings, age, overall health and how well the earlier condition is controlled, so the care team's view of the specific leukemia matters more than general figures. Intensive treatment usually means weeks in the hospital during induction, followed by further courses of therapy or preparation for transplant. Blood counts fall during treatment, so transfusions, infection prevention and frequent blood tests are part of daily life, and fatigue is common. People are often managing the after-effects of their earlier cancer treatment at the same time, which can make recovery slower. Treatment at a center experienced in leukemia and transplant, along with support for practical, emotional and financial strain, helps people and families plan.

When to Seek Help

If you have had radiation therapy or chemotherapy in the past, keep up with follow-up blood tests and arrange a visit if you notice unusual tiredness, easy bruising or bleeding, tiny red dots under the skin, repeated infections or shortness of breath with ordinary activity. During leukemia treatment, call your care team right away for a fever of 100.5 F (38 C) or higher or shaking chills, because infections when blood counts are low can become life-threatening quickly.

Questions to Ask Your Doctor

  1. 1.What do the genetic and chromosome findings on my leukemia mean for my outlook and treatment choices?
  2. 2.Am I a candidate for intensive chemotherapy or a stem cell transplant, and what would each involve for me?
  3. 3.How do the effects of my earlier cancer treatment change what treatments are safe for me?
  4. 4.Should I or my family have genetic counseling or inherited gene testing?
  5. 5.Is there a clinical trial that fits my situation?

Last reviewed • Oct 2026

Educational content, not medical advice.